KYTX icon

Kyverna Therapeutics
KYTX

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$29
262% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Wells Fargo
Wells Fargo
Derek Archila
67% 1-yr KYTX win rate
16 Dec ‘25 1 month ago
Morgan Stanley
Morgan Stanley
Michael Ulz
100% 1-yr KYTX win rate
4 Dec ‘25 1 month ago